文献速递创伤骨科骨质疏松与代谢性骨病

抗组胺药使用与老年患者伤害性跌倒或骨折风险:系统综述与荟萃分析

Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis.
PubMed 文献 · Osteoporos Int · 2018-07-25

该系统综述与荟萃分析纳入5项观察性研究(3项病例对照、1项队列、1项病例交叉),评估老年患者使用抗组胺药与伤害性跌倒或骨折风险的关联。第一代抗组胺药使用与伤害性跌倒或骨折风险显著增加相关(OR 2.03,95%CI 1.49-2.76);包含所有代际或无代际信息的抗组胺药研究涉及住院期间跌倒,关联亦显著(OR 2.89,95%CI 1.71-4.89)。作者结论为临床医生给老年患者处方第一代抗组胺药时需谨慎。

要点

  • 第一代抗组胺药使用与老年患者伤害性跌倒或骨折风险显著增加相关(OR 2.03,95%CI 1.49-2.76)。
  • 包含所有代际或无代际信息的抗组胺药研究涉及住院期间跌倒,关联显著(OR 2.89,95%CI 1.71-4.89)。
  • 临床医生给老年患者处方第一代抗组胺药时需谨慎。

核心结论

  • 第一代抗组胺药使用与老年患者伤害性跌倒或骨折风险显著增加相关。
  • 临床医生给老年患者处方第一代抗组胺药时需谨慎。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE及若干本地数据库至2016年11月。
  • 从473项识别的研究中纳入5项观察性研究:3项病例对照研究、1项队列研究、1项病例交叉研究。
  • 评估研究质量与证据等级,采用随机效应模型进行荟萃分析,基于I平方和Cochrane Q检验检查异质性,异质性无法解释时进行亚组分析。

主要发现

  • 第一代抗组胺药使用显示伤害性跌倒或骨折风险显著增加(OR 2.03,95%CI 1.49-2.76,异质性P=0.41,I²=0%)。
  • 包含所有代际或无代际信息的抗组胺药研究涉及住院期间跌倒,关联有统计学显著性且无异质性(OR 2.89,95%CI 1.71-4.89,异质性P=0.42,I²=0%)。

临床怎么用

  • 作者结论指出,临床医生给老年患者处方第一代抗组胺药时需谨慎。

局限性

  • 由于纳入研究数量少且结果未校正,基于亚组分析的有意义解读受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Despite their anticholinergic side effects, first-generation antihistamines are widely prescribed to elderly patients. A systematic review was conducted to synthesize real-world evidence. First-generation antihistamine use is considerably associated with an increased risk of injurious falls or fracture among the elderly. INTRODUCTION: First-generation antihistamines are considered potentially inappropriate for elderly patients owing to anticholinergic side effects. We aimed to determine whether elderly patients taking antihistamines are at increased risk of injurious falls or fracture. METHODS: We identified studies in MEDLINE, EMBASE, and several local databases through November 2016. Observational studies on the association between antihistamine use and the risk of injurious falls or fracture were selected. Quality of the studies and the level of evidence were assessed. The random-effects model was employed for meta-analysis, and heterogeneity was examined based on I-square and Cochrane's Q test. Subgroup analyses were performed when the heterogeneity among studies could not be explained. RESULTS: From 473 identified studies, five (three case-control studies, one cohort study, and one case-crossover study) were included in our analysis based on eligibility criteria. First-generation antihistamine use showed significantly increased risk of injurious falls or fracture (odds ratio [OR] 2.03, 95% confidence interval [CI] 1.49-2.76, heterogeneity: p = 0.41, I2 = 0%). Studies including antihistamines of all generations or containing no generation information were dealing with falls during hospitalization. Among these studies, the association was statistically significant without heterogeneity (OR 2.89, 95% CI 1.71-4.89, heterogeneity: p = 0.42, I2 = 0%). Due to the small number of studies included and unadjusted results, meaningful interpretation based on subgroup analysis was limited. CONCLUSIONS: First-generation antihistamine use is considerably associated with increased risk of injurious falls or fracture among the elderly. Clinicians need to exercise caution when prescribing first-generation antihistamines to elderly patients.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Cho H, Myung J, Suh HS, et al. Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis. Osteoporos Int. 2018. PMID: 30046925. doi:10.1007/s00198-018-4564-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。